Tremendous efforts have been made to develop kinase inhibitors as cancer treatments In a paper published April 12 in the journal Cell, a team from the University of North Carolina at Chapel... Read more
Kills 2 million people annually A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) — a disease that kills 2 million people a... Read more
Cellceutix believes it has found the Holy Grail in cancer research . . . a compound that activates a tumor suppressor protein known as p53, long regarded as possibly holding the key t... Read more
It could save hundreds of thousands of lives each year It uses ultra-small plastic particles that attach to bacteria and drill holes in their cell walls, causing the bacteria to collapse and... Read more